Skip to content

Monday, Dec 4, 2023

Breaking News

Oxford Nanopore Technologies and Saphetor Announce a New Partnership to Deliver Tertiary Analysis for Comprehensive Interpretation of Nanopore Sequencing

Henry Schein Completes Acquisition of a Majority Interest in Shield Healthcare, Inc.

Verily and OneOncology Announce Collaboration to Advance Cancer Research

Simplify Healthcare Is Positioned in the Leaders Category in the 2023 IDC MarketScape for U.S. Health Plan Product/Plan Benefit Configuration Solutions

ADARx Pharmaceuticals, A Leader in Next Generation RNA Therapeutics, Announces Oversubscribed $200 Million Series C Financing

Hims & Hers Expands Into Cardiovascular Health with New Dual-Action Capabilities

Bright Health Group Secures Financing to Support Operations Pending the Expected Close of California Medicare Advantage Business Sale

Henry Schein Acquires a Majority Interest in Large Practice Sales LLC, a Leading Transaction Advisory Services Business

Guardant resolves pending litigation with Illumina and enters into new agreement to advance long-term commercial partnership and cancer research

Medisca is expanding strategic partnerships to improve patient access to much-needed medicines

QuidelOrtho Ranks No. 1 in Customer Satisfaction for Six Years in a Row

Astellas Completes Acquisition of Iveric Bio

News
- Featured News
- Trending News
Events
Companies
Resources
Blogs

Search for:

Nothing Found

It seems we can’t find what you’re looking for. Perhaps searching can help.

Search for:

Recent Posts

1
Oxford Nanopore Technologies and Saphetor Announce a New Partnership to Deliver Tertiary Analysis for Comprehensive Interpretation of Nanopore Sequencing
October 25, 2023
2
Henry Schein Completes Acquisition of a Majority Interest in Shield Healthcare, Inc.
October 18, 2023
3
Verily and OneOncology Announce Collaboration to Advance Cancer Research
August 17, 2023
4
Simplify Healthcare Is Positioned in the Leaders Category in the 2023 IDC MarketScape for U.S. Health Plan Product/Plan Benefit Configuration Solutions
August 10, 2023
5
ADARx Pharmaceuticals, A Leader in Next Generation RNA Therapeutics, Announces Oversubscribed $200 Million Series C Financing
August 9, 2023

Click TO Unsubscribe

Useful Link

Privacy Policy
Terms Of Service
Cookies

Email Subscriber

Email*

Social Media Icons

Visit Us On Twitter

Visit Us On Facebook

Visit Us On Linkedin

Click To Data Request

2023 TheHealth.info All Rights Reserved Privacy Policy WordPress Theme: Seek by ThemeInWP

Please wait...

Subscribe to our newsletter

Want to be notified when our article is published? Enter your email address and name below to be the first to know.

SIGN UP FOR NEWSLETTER NOW